Progressive Care Inc.
Reports 47%
Increase in Prescriptions
Filled During July 2018
Miami,
FL -- August 21,
2018 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD),
a personalized
healthcare
services and technology company,
today announced further
growth year-over-year in both revenue and number of prescriptions
filled for July 2018. July
brought a total of $1.887 million in
net revenue, an
increase of 10.5% from last year in the same month, and
a 47%
increase in prescriptions filled over
the same month last year, totaling approximately 26,777
prescriptions.
Progressive
Care's wholly owned subsidiary PharmCo, LLC has seen
a
28.46% increase in prescriptions
filled in
July over
the same month last year, totaling approximately
23,390
prescriptions.
The company's
Touchpoint Pharmacy has seen a 15.5%
increase in prescriptions filled over the same month last year,
totaling approximately 3,387 prescriptions, and a 35% increase in
revenue, totaling approximately $138,000. This growth is a result
of Progressive Care's increased management involvement following
the completed acquisition
of the
pharmacy in early July of this year.
"Progressive
Care's strong July sales and prescription numbers
are a result
of our dedicated commitment
to providing
patients a full
range of personalized medication therapies," said S. Parikh Mars, Chief
Executive Officer of Progressive Care Inc. "We are proud that in just the
first month of having Touchpoint
Pharmacy as
part of our offering, we were able to see
an increase in both
revenue and prescriptions filled at that location. We anticipate
that the new pharmacy will greatly contribute to our
ongoing expansion success in the next 12
months."
The release of
July 2018 sales figures follows
Progressive
Care's recently released Q2 2018
financial results, where the company reported its
largest six-month revenue period in company history
and the beginning
of its uplisting process to one of the national
exchanges with the start of registering with SEC.
Earlier
this month, the company also announced that
it had
paid
off its convertible note to Chicago Venture Partners through an
issuance of common stock. The
issuance of 1,974,279 shares of Progressive Care stock on August 8,
2018,
brought
the
company to a balance of zero.
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care, Inc.
Progressive Care
Inc. (OTCQB:RXMD), through its PharmCo, LLC, is
a South Florida health services organization and provider of
prescription pharmaceuticals, compounded medications, provider of
tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current
or historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Tory Patterson,
CMW Media
Public Relations
Consultant
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com